A time-domain diffuse fluorescence and optical tomography system for breast tumor diagnosis

ZHANG Wei; GAO Feng; WU Lin-Hui; MA Wen-Juan; LU Yi-Ming; ZHAO Hui-Juan

doi:10.3724/sp.j.1010.2013.00181

[1] Van de Ven S M W Y, Elias S G, Van de Bosch M A A J, et al. Optical imaging of the breast [J]. Cancer imaging, 2008, 8(1): 206-215.

[2] Durdran T, Choe R, Baker W B, et al. Diffuse optics for tissue monitoring and tomography [J]. Rep. Prog. Phys., 2010, 73(7): 076701.

[3] Leff D R, Warren O J, Enfield L C, et al. Diffuse optical imaging of the healthy and diseased breast: a systematic review [J]. Breast Cancer Res. Treat., 2008, 108(1): 9-22.

[4] Tromberg B J, Pogue B W, Paulsen K D, et al. Assessing the future of diffuse optical imaging technologies for breast cancer management [J]. Med. Phys., 2008, 35(6): 2443-2451.

[5] Demos S G, Vogel A J, Gandjbakhche A H. Advances in optical spectroscopy and imaging of breast lesions [J]. J. Mammary Gland Biol. Neoplasia, 2006, 11(2): 165-181.

[6] Li C, Grobmyer S R, Massol N, et al. Noninvasive in vivo tomographic optical imaging of cellular morphology in the breast: possible convergence of microscopic pathology and macroscopic radiology [J]. Med. Phys., 2008, 35(6): 2493-2501.

[7] Taroni P, Pifferi A, Salvagnini E, et al. Seven-wavelength time-resolved optical mammography extending beyond 1000 nm for breast collagen quantification [J]. Opt. Express, 2009, 17(18): 15932-15946.

[8] Li C Q, Zhao H Z, Anderson B, et al. Multispectral breast imaging using a ten-wavelength, 64×64 source/detector channels silicon photodiode-based diffuse optical tomography system [J]. Med. Phys., 2006, 33(3): 627-636.

[9] Zhu Q, Kurtzman S H, Hegde P, et al. Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers [J]. Neoplasia, 2005, 7(3): 263-270.

[10] Carpenter C M, Srinivasan S, Pogue B W, et al. Methodology development for three-dimensional MR-guided near-infrared spectroscopy of breast tumors [J]. Opt. Express, 2008, 16(22): 17903-17914.

[11] Carpenter C M, Pogue B W, Jiang S, et al. MR Water Quantitative Priors Improves the Accuracy of Optical Breast Imaging [J]. IEEE Trans Med Imaging, 2011, 30(1): 159-168.

[12] Hagen A, Grosenick D, Macdonald R, et al. Late-fluorescence mammography assesses tumor capillary permeability and differentiates malignant from benign lesions [J]. Opt. Express, 2009, 17(19): 17016-17033.

[13] RynoldS J S, Troy T L, Mayer R H, et al. Imaging of spontaneous canine mammary tumors using fluorescent contrast agents [J]. Photochem. Photobiol., 1999, 70(1): 87-94.

[14] Corlu A, Choe R, Durduran T, et al. Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans [J]. Opt. Express, 2007, 15(11): 6696-6716.

[15] Van de Ven S, Wiethoff A, Nielsen T, et al. A novel fluorescent imaging agent for diffuse optical tomography of the breast: First clinical experiment in patients [J]. Mol. Imaging Biol., 2010, 12(3): 343-348.

[16] Yang XQ, Gong H, Quan GT, et al. Combined system of fluorescence diffuse optical tomography and microcomputed tomography for small animal imaging [J]. Rev. Sci. Instrum., 2010, 81(5): 054304.

[17] Deliolanis N, Lasser T, HydedD, et al. Free-space fluorescence molecular tomography utilizing 360° geometry projections [J]. Opt. Lett., 2007, 32(4): 382-384.

[18] Gao F, Zhao HJ, TanikawayY, et al. Time-resolved diffuse optical tomography using a modified generalized pulse spectrum technique [J]. IEICE TRANS. INF. & SYST., 2002, 85(1): 133-142.

[19] Gao F, Zhao HJ, TanikawayY, et al. A linear, featured-data scheme for image reconstruction in time-domain fluorescence molecular tomography [J]. Opt. Express, 2006, 14(16): 7109-7124.